Homology modeling of MT1 and MT2 receptors.

[1]  K. Berka,et al.  Ligand binding to the human MT2 melatonin receptor: the role of residues in transmembrane domains 3, 6, and 7. , 2005, Biochemical and biophysical research communications.

[2]  T. Schwartz,et al.  High Constitutive Activity of a Virus-Encoded Seven Transmembrane Receptor in the Absence of the Conserved DRY Motif (Asp-Arg-Tyr) in Transmembrane Helix 3 , 2005, Molecular Pharmacology.

[3]  M. Mor,et al.  Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models. , 2005, Journal of medicinal chemistry.

[4]  Karel Berka,et al.  Molecular modeling of human MT2 melatonin receptor: the role of Val204, Leu272 and Tyr298 in ligand binding , 2004, Journal of neurochemistry.

[5]  N. Sarbin,et al.  4-Substituted anilides as selective melatonin MT2 receptor agonists. , 2004, Bioorganic & medicinal chemistry letters.

[6]  M. Dubocovich,et al.  Mutagenesis studies of the human MT2 melatonin receptor. , 2003, Biochemical pharmacology.

[7]  O. Vakkuri,et al.  Important amino acids for the function of the human MT1 melatonin receptor. , 2003, Biochemical pharmacology.

[8]  M. J. Jarzynka,et al.  Melatonin receptors and their regulation: biochemical and structural mechanisms. , 2003, Life sciences.

[9]  R. Mattson,et al.  Indanyl piperazines as melatonergic MT2 selective agents. , 2003, Bioorganic & medicinal chemistry letters.

[10]  Robert S. Ledley,et al.  The Protein Information Resource , 2003, Nucleic Acids Res..

[11]  S. Hinuma,et al.  Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists. , 2002, Journal of medicinal chemistry.

[12]  F. Mseeh,et al.  Identification of cysteines involved in ligand binding to the human melatonin MT(2) receptor. , 2002, European journal of pharmacology.

[13]  S. White,et al.  How Membranes Shape Protein Structure* , 2001, The Journal of Biological Chemistry.

[14]  O. Nosjean,et al.  Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2 . , 2001, Biochemical pharmacology.

[15]  P. Morgan,et al.  Serine residues 110 and 114 are required for agonist binding but not antagonist binding to the melatonin MT(1) receptor. , 2001, Biochemical and biophysical research communications.

[16]  J. Nicolas,et al.  Synthesis of phenalene and acenaphthene derivatives as new conformationally restricted ligands for melatonin receptors. , 2000, Journal of medicinal chemistry.

[17]  O. Nosjean,et al.  Identification of the Melatonin-binding SiteMT 3 as the Quinone Reductase 2* , 2000, The Journal of Biological Chemistry.

[18]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[19]  P. Morgan,et al.  Chimeric Melatonin mt1 and Melatonin-related Receptors , 2000, The Journal of Biological Chemistry.

[20]  I. Longden,et al.  EMBOSS: the European Molecular Biology Open Software Suite. , 2000, Trends in genetics : TIG.

[21]  J. Drews.  Drug discovery: a historical perspective. , 2000, Science.

[22]  A. Gubitz,et al.  Chimeric and point-mutated receptors reveal that a single glycine residue in transmembrane domain 6 is critical for high affinity melatonin binding. , 2000, Endocrinology.

[23]  E. Hulme,et al.  The conformational switch in 7-transmembrane receptors: the muscarinic receptor paradigm. , 1999, European journal of pharmacology.

[24]  S. Dowell,et al.  Mutagenesis of human Mel1a melatonin receptor expressed in yeast reveals domains important for receptor function. , 1998, Biochemical and biophysical research communications.

[25]  J. Thompson,et al.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. , 1997, Nucleic acids research.

[26]  P. Morgan,et al.  The roles of valine 208 and histidine 211 in ligand binding and receptor function of the ovine Mel1a beta melatonin receptor. , 1997, Biochemical and biophysical research communications.

[27]  R. Nonno,et al.  Conformationally restrained melatonin analogues: synthesis, binding affinity for the melatonin receptor, evaluation of the biological activity, and molecular modeling study. , 1997, Journal of medicinal chemistry.

[28]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[29]  A. Poso,et al.  A rhodopsin-based model for melatonin recognition at its G protein-coupled receptor. , 1996, European journal of pharmacology.

[30]  D. Lewis,et al.  Structural requirements at the melatonin receptor , 1995, British journal of pharmacology.

[31]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[32]  S. Reppert,et al.  Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses , 1994, Neuron.

[33]  P. Depreux,et al.  Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands. , 1994, Bioorganic & medicinal chemistry.

[34]  G Vriend,et al.  A common step for signal transduction in G protein-coupled receptors. , 1994, Trends in pharmacological sciences.

[35]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[36]  D. Lesieur,et al.  Novel naphthalenic ligands with high affinity for the melatonin receptor. , 1992, Journal of medicinal chemistry.

[37]  R. Cramer,et al.  Validation of the general purpose tripos 5.2 force field , 1989 .

[38]  D Eisenberg,et al.  Hydrophobic organization of membrane proteins. , 1989, Science.

[39]  M. Dubocovich,et al.  Luzindole (N-0774): a novel melatonin receptor antagonist. , 1988, The Journal of pharmacology and experimental therapeutics.

[40]  O. Vakkuri,et al.  Iodinated melatonin: preparation and characterization of the molecular structure by mass and 1H NMR spectroscopy. , 1984, Analytical biochemistry.

[41]  O. Vuolteenaho,et al.  Development and validation of a melatonin radioimmunoassay using radioiodinated melatonin as tracer. , 1984, Acta endocrinologica.

[42]  U. Singh,et al.  A NEW FORCE FIELD FOR MOLECULAR MECHANICAL SIMULATION OF NUCLEIC ACIDS AND PROTEINS , 1984 .

[43]  J. Nathans,et al.  Isolation, sequence analysis, and intron-exon arrangement of the gene encoding bovine rhodopsin , 1983, Cell.

[44]  E. Bittman,et al.  Role of the pineal gland in ovine photoperiodism: regulation of seasonal breeding and negative feedback effects of estradiol upon luteinizing hormone secretion. , 1983, Endocrinology.

[45]  David Eisenberg,et al.  The helical hydrophobic moment: a measure of the amphiphilicity of a helix , 1982, Nature.

[46]  A. Lerner,et al.  STRUCTURE OF MELATONIN1 , 1959 .

[47]  Bernard Maigret,et al.  Rhodopsin crystal: new template yielding realistic models of G-protein-coupled receptors? , 2003, Trends in pharmacological sciences.

[48]  Lei Xie,et al.  Using multiple structure alignments, fast model building, and energetic analysis in fold recognition and homology modeling , 2003, Proteins.

[49]  Luhua Lai,et al.  Further development and validation of empirical scoring functions for structure-based binding affinity prediction , 2002, J. Comput. Aided Mol. Des..

[50]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[51]  P. Witt-Enderby,et al.  Melatonin receptors as potential targets for drug discovery , 2000 .

[52]  S. Folkard,et al.  Can melatonin improve shift workers' tolerance of the night shift? Some preliminary findings. , 1993, Chronobiology international.

[53]  M. Lehman,et al.  Influences of the paraventricular and suprachiasmatic nuclei and olfactory bulbs on melatonin responses in the golden hamster. , 1989, Biology of reproduction.

[54]  J. Adair,et al.  Induction of winter fur growth in mink (Mustela vison) with melatonin. , 1984, Journal of animal science.

[55]  F. Goodwin,et al.  Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. , 1984, Archives of general psychiatry.